Search CatalystAlert
Search for companies, drugs, and catalysts
Search CatalystAlert
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Phase 2
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No catalyst events have been recorded for this drug yet.
0 competitors in Multiple Sclerosis, Relapsing-Remitting
View Full LandscapeTarget Indication
Multiple Sclerosis, Relapsing-Remitting
Clinical Trial
NCT00220779Last updated: 2/13/2026
No patent data available. Pre-approval drugs may not have Orange Book listings.
Decompensated Cirrhosis and Ascites
Target Bleeding Site During Peripheral Vascular Surgery
Alpha₁-Antitrypsin Deficiency
Alpha 1-Antitrypsin Deficiency
Alpha 1-Antitrypsin Deficiency